Bridging Oncology and Autoimmune Disease: Using QSP to Select T-Cell Engager Doses by CRS Risk and Efficacy
Explore how QSP modeling informs T-cell engager dose selection for autoimmune diseases, balancing efficacy and…
Piet van der GraafOctober 26, 2026
Leveraging a QSP Platform for Prediction of Clinical Efficacy and Safety Biomarkers in Immuno-Oncology Combination Therapy
Learn how Certara's IO Simulator QSP platform predicts combination efficacy and cytokine biomarkers of cytokine…
CertaraOctober 20, 2026
Strategy Starts at Discovery: Using QSP to Choose the Right Indication, the Right Asset, and the Right Path to First-in-Human
Watch the webinar to learn how QSP and a model-informed target product profile guide indication,…
Danielle PillsburyOctober 9, 2026
Why peptide sequence alignment needs its own analytics — Not a small molecule workaround
JTVCdGVhbV9qdW1wX2xpc3QlNUQ= October 9, 2026 Peptide therapeutics are expanding quickly. Approvals have climbed at an accelerating…
Anikó Horváth-FarkasOctober 9, 2026
